Axon Neuroscience's active tau immunotherapy AADvac1 has been selected as the first tau-targeted therapy to enter a ...
The country is facing a coming wave of dementia for its ageing population, and is investing in research into drugs, ...
Forty-Hz auditory stimulation increased amyloid clearance markers in aged primates and produced lasting effects, supporting its potential as a non-invasive Alzheimer’s therapy. Scientists at the Kunmi ...
A new blood test could predict when Alzheimer’s will strike — years before symptoms begin. Scientists at Washington University School of Medicine in St. Louis have created a way to estimate when a ...
Mandara Biopharma Inc. announced approval from the FDA to initiate their clinical trials for the treatment of agitation ...
Science’s success at staving off death from heart disease or cancer has made another diagnosis more likely: Dementia.
The technique is not yet precise enough to predict a patient’s exact trajectory but could help find long-sought preventive treatment.